Patients with CHI have an abnormal insulin secretory capacity or an abnormal glucose-sensing mechanism, which results in the failure to reduce pancreatic insulin secretion even in the presence of hypoglycemia6. This evidence concerns the gene INS and congenital isolated hyperinsulinism.